https://www.selleckchem.com/pr....oducts/pterostilbene
Most TEAEs were mild or moderate, with no serious drug-related TEAEs. The most common TEAEs were upper respiratory tract infections, abdominal pain, diarrhea, and vomiting. Mean (±standard error of the mean) monthly attack rates at baseline and week 48 were 3.06 (±0.25) and 1.06 (±0.25) in the berotralstat 150mg 48-week group and 2.97 (±0.21) and 1.35 (±0.33) in the berotralstat 110mg 48-week group. The safety, tolerability, and effectiveness of berotralstat were maintained over 48 weeks of treatment. The safety, tolerability, and
Like
Comment
Share
